Xu, Lejia
90  results:
Search for persons X
?
2

CM082 Enhances the Efficacy of Chemotherapeutic Drugs by In..:

Xu, Lejia ; Huang, Jiwei ; Liu, Jie...
Molecular Therapy - Oncolytics.  31 (2023)  - p. 100746 , 2023
 
?
3

The atypical Rab GTPase associated with Parkinson's disease..:

Nagai-Ito, Yuki ; Xu, Lejia ; Ito, Kyohei...
Journal of Biological Chemistry.  298 (2022)  10 - p. 102499 , 2022
 
?
8

CM082 Enhances the Efficacy of Chemotherapeutic Drugs by In..:

Xu, Lejia ; Huang, Jiwei ; Liu, Jie...
Molecular Therapy - Oncolytics.  16 (2020)  - p. 100-110 , 2020
 
?
9

Off-Label Drug Use Medication Guidelines of Immunotherapy D..:

Li Ye ; Liu Xingling ; Pan Yunqi...
https://www.xinyixue.cn/fileup/0253-9802/PDF/1677813443243-1771753839.pdf.  , 2023
 
?
10

Efficacy and safety of voriconazole in the treatment of inv..:

Yu, Xue ; Xu, Lejia ; Zheng, Jiaxing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10726598/.  , 2023
 
?
11

Spinal canal infection caused by Streptococcus suis in huma..:

Xu, Lejia ; Wang, Xiaoyun ; Lei, Ziying...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003998/.  , 2022
 
?
 
?
13

Clinical features and risk factors of surgical site infecti..:

Xu, Lejia ; Zhu, Jianyun ; Wang, Xiaoyun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476323/.  , 2022
 
?
14

The atypical Rab GTPase associated with Parkinson's disease..:

Nagai-Ito, Yuki ; Xu, Lejia ; Ito, Kyohei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574512/.  , 2022
 
?
15

The Regulation of Rab GTPases by Phosphorylation:

Xu, Lejia ; Nagai, Yuki ; Kajihara, Yotaro..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469595/.  , 2021
 
1-15